Literature DB >> 17250674

The role of the plasmalemmal dopamine and vesicular monoamine transporters in methamphetamine-induced dopaminergic deficits.

Trent J Volz1, Glen R Hanson, Annette E Fleckenstein.   

Abstract

Amphetamine (AMPH) and methamphetamine (METH) are members of a collection of phenethylamine psychostimulants that are commonly referred to collectively as "amphetamines." Amphetamines exert their effects, in part, by affecting neuronal dopamine transport. This review thus focuses on the effects of AMPH and METH on the plasmalemmal dopamine transporter and the vesicular monoamine transporter-2 in animal models with a particular emphasis on how these effects, which may vary for the different stereoisomers, contribute to persistent dopaminergic deficits.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17250674     DOI: 10.1111/j.1471-4159.2006.04419.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  37 in total

1.  A role for casein kinase 1 epsilon in the locomotor stimulant response to methamphetamine.

Authors:  Camron D Bryant; Melissa E Graham; Margaret G Distler; Michaelanne B Munoz; Dongdong Li; Paul Vezina; Greta Sokoloff; Abraham A Palmer
Journal:  Psychopharmacology (Berl)       Date:  2008-12-03       Impact factor: 4.530

2.  S(+)amphetamine induces a persistent leak in the human dopamine transporter: molecular stent hypothesis.

Authors:  Aldo A Rodriguez-Menchaca; Ernesto Solis; Krasnodara Cameron; Louis J De Felice
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

3.  The Basal Ganglia as a Substrate for the Multiple Actions of Amphetamines.

Authors:  Reka Natarajan; Bryan K Yamamoto
Journal:  Basal Ganglia       Date:  2011-07-01

4.  The Role of HINT1 in Methamphetamine-Induced Conditioned Place Preference.

Authors:  Ju-Ping Li; Peng Liu; Gang Lei; Zheng Chu; Fei Liu; Chao-Feng Shi; Yong-Hui Dang; Teng Chen
Journal:  Neurotox Res       Date:  2017-08-26       Impact factor: 3.911

5.  Role of dopamine D2-like receptors and their modulation by adenosine receptor stimulation in the reinstatement of methamphetamine seeking.

Authors:  Tracey A Larson; Madeline C Winkler; Jacob Stafford; Sophia C Levis; Casey E O'Neill; Ryan K Bachtell
Journal:  Psychopharmacology (Berl)       Date:  2018-11-23       Impact factor: 4.530

6.  Methylphenidate-induced alterations in synaptic vesicle trafficking and activity.

Authors:  Trent J Volz; Sarah J Farnsworth; Glen R Hanson; Annette E Fleckenstein
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

7.  Comparison of systemic and local methamphetamine treatment on acetylcholine and dopamine levels in the ventral tegmental area in the mouse.

Authors:  L K Dobbs; G P Mark
Journal:  Neuroscience       Date:  2008-08-03       Impact factor: 3.590

8.  Evaluation of modafinil effects on cardiovascular, subjective, and reinforcing effects of methamphetamine in methamphetamine-dependent volunteers.

Authors:  Richard De La Garza; Todd Zorick; Edythe D London; Thomas F Newton
Journal:  Drug Alcohol Depend       Date:  2009-09-24       Impact factor: 4.492

9.  Methylphenidate-induced increases in vesicular dopamine sequestration and dopamine release in the striatum: the role of muscarinic and dopamine D2 receptors.

Authors:  Trent J Volz; Sarah J Farnsworth; Shane D Rowley; Glen R Hanson; Annette E Fleckenstein
Journal:  J Pharmacol Exp Ther       Date:  2008-06-30       Impact factor: 4.030

10.  Neuropharmacological mechanisms underlying the neuroprotective effects of methylphenidate.

Authors:  T J Volz
Journal:  Curr Neuropharmacol       Date:  2008-12       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.